Food and Drug Administration

Oncologic Drugs Advisory Committee

May 3, 2004


Genasense™ (oblimersen sodium) Injection for Advanced Melanoma in Combination With Dacarbazine (DTIC) - Introduction, Dr. Loretta Itri, MD, Genta Inc. (PDF)

FDA Presentation: Genasense (Oblimersen) for Metastatic Melanoma, Dr. Robert Kane, MD & Dr. Peiling Yang, PhD (HTM) (PPT)

Efaproxiral (RSR13) as an Adjunct to Whole Brain Radiation Therapy for the Treatment of Brain Metastases Originating From Breast Cancer, Dr. Pablo Cagnoni, MD, Allos Therapeutics (HTM) (PPT)

FDA Presentation: NDA 21-661 RSR13 (efaproxiral sodium), Dr. Rajeshwari Sridhara, PhD & Dr. Kevin Ridenhour, MD (HTM) (PPT)

Subgroup Analyses in Clinical Trials, Dr. Stephen George, PhD, Duke University Medical Center (HTM) (PPT)

Open Public Hearing

List of AM Speakers (HTM)(PPT)

The Need for Better Rx's, Dr. Lawrence Green, MD, The Skin Cancer Foundation (HTM) (PPT)

List of PM Speakers (HTM) (PPT)